StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
CDT

CDT Equity Inc.

CDT Nasdaq Pharmaceutical Preparations EDGAR ↗
$3.00
+0.14 +4.85%

Key statistics

from XBRL data in SEC filings
Market cap
$19.0M
Revenue (TTM)
Net income (TTM)
-$38.5M
EPS (TTM)
$2,486.82
P/E ratio
0.0
Dividend yield
Free cash flow
-$15.6M
Cash
$97.0K
Total assets
$127M
Gross margin
52-week range
$2.53 – $3,800.00

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K/A Completed an acquisition or disposition Aug 3, 2026 8-K Entered a material agreement; Unregistered sale of equity Jul 31, 2026 8-K Unregistered sale of equity Jul 29, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Jul 16, 2026 10-Q Quarter ended 2026-03-31 Jul 15, 2026 8-K Entered a material agreement; Took on a direct financial obligation Jul 7, 2026 8-K Changed accountants Jun 29, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Jun 16, 2026 8-K Delisting notice or listing-rule failure; Regulation FD disclosure May 28, 2026 8-K Entered a material agreement May 15, 2026 8-K Director or officer change Apr 27, 2026 10-K Fiscal year ended 2025-12-31 Apr 15, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Mar 25, 2026 8-K Shareholder vote results Mar 18, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Mar 9, 2026 8-K Entered a material agreement; Unregistered sale of equity Feb 24, 2026 8-K Entered a material agreement; Unregistered sale of equity Jan 22, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jan 2, 2026 8-K Entered a material agreement; Unregistered sale of equity Dec 12, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Oct 9, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 10-Q/A Quarter ended 2025-03-31 Aug 14, 2025 8-K Previously issued financials not reliable Aug 14, 2025 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results; Regulation FD disclosure Aug 8, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jun 9, 2025 8-K Item 5.08 Jun 3, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure May 16, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Shareholder vote results May 6, 2025 8-K Changed accountants Apr 25, 2025 8-K Director or officer change; Regulation FD disclosure Apr 16, 2025 8-K Entered a material agreement; Unregistered sale of equity Apr 4, 2025 8-K/A Other events Apr 2, 2025 8-K Other events Apr 1, 2025 10-K Fiscal year ended 2024-12-31 Mar 28, 2025 8-K Other events Mar 6, 2025 8-K Terminated a material agreement; Delisting notice or listing-rule failure; Other events Feb 19, 2025 8-K Other events Feb 11, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Jan 23, 2025